Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
There were also differences in reported GLP-1RA use in different races
A typical approach involves using Retatrutide throughout the entire steroid cycle plus several weeks into post-cycle therapy (PCT)
A research team led by endocrinologist Prathiba Natesh in the Department of Endocrinology at Warwick Medical School, University of Warwick, UK, conducted a meta-analysis of randomized controlled clinical trials of GLP-1 drugs that included testosterone measurements and presented their findings at the Endocrine Society meeting
Notably, the researchers did not observe any change in melatonin levels in young monkeys who were given the same treatment [7]
US$ 22.67
US$ 28.69
US$ 20.62
US$ 23.60
US$ 26.45
US$ 24.87
